The Alzheimer’s Research UK Drug Discovery Alliance will couple the deep disease knowledge and biology expertise of the academic community with high quality, innovative drug discovery technologies.

Housed within the Cruciform Building, in the heart of UCL’s Bloomsbury Campus, the Drug Discovery Institute will draw on a wealth of disease expertise to generate well validated targets and optimised leads. We are looking for academic researchers who have targets and ideas with translational potential, keen to partner with us to fast-track these ideas towards new medicines.

The Alzheimer’s Research UK University College London Drug Discovery Institute is one of three Institutes within the Drug Discovery Alliance, working alongside Institutes at the University of Cambridge and University of Oxford. The Alliance will accelerate the discovery of novel, effective therapeutics for Alzheimer’s disease and other neurodegenerative diseases.

About the Institute

Find out more

Academic collaborations

Find out more

New industry partnerships

Find out more

Our team

Find out more